Bradley Why
Psychiatric/Mental Health · Newark, DENPI 1871821322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$908
- AbbVie$902
- Alkermes, Inc.$650
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$534
- Johnson & Johnson$444
- Takeda Pharmaceuticals U.S.A., Inc.$405
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,66498%
- Education$1362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 49 | $908 |
| AbbVie | 66 | $902 |
| Alkermes, Inc. | 48 | $650 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $534 |
| Johnson & Johnson | 27 | $444 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $405 |
| Otsuka America Pharmaceutical, Inc. | 26 | $399 |
| Supernus Pharmaceuticals, Inc. | 27 | $389 |
| Axsome Therapeutics, Inc. | 20 | $281 |
| Sunovion Pharmaceuticals Inc. | 15 | $256 |
| Tris Pharma Inc | 10 | $165 |
| Neurocrine Biosciences, Inc. | 8 | $164 |
| Corium, LLC | 3 | $67 |
| Jazz Pharmaceuticals Inc. | 4 | $60 |
| Braeburn Inc. | 3 | $50 |
| Ironshore Pharmaceuticals Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$5,800 in reported general payments places this provider in the 95th percentile of 177 psychiatric/mental health providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $117,340 |
| Lurasidone Hcl | 19 | $21,031 |
| TrintellixVortioxetine Hydrobromide | 32 | $16,259 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $3,049 |
| Fluoxetine Hcl | 57 | $1,714 |
| Bupropion XlBupropion Hcl | 26 | $1,252 |
| Duloxetine Hcl | 54 | $1,148 |
| Quetiapine Fumarate | 33 | $848 |
| Aripiprazole | 15 | $730 |
| Olanzapine | 39 | $691 |
| Alprazolam | 38 | $581 |
| Clonazepam | 38 | $521 |
| Gabapentin | 28 | $414 |
| Bupropion Hcl SrBupropion Hcl | 13 | $330 |
| Trazodone Hcl | 33 | $293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $164 | $117,34012 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $405 | $16,25932 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 177 psychiatric/mental health providers in Delaware.
Other psychiatric/mental health in Newark
- Kameka HartNewark$10K
- Ema SohnaNewark$5K
- Kareemah HammondNewark$4K
- Tiffany DysonNewark$3K
- Bernadette MomohNewark$3K
- Stefanie FerraroNewark$2K
- Catherine LukoNewark$2K
- Ronald TyreeWilmington$59K
- Ericka Taylor-DanielDover$39K
- Cindy CunninghamDover$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.